Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for managing type 2 diabetes but increasingly recognised for their weight management properties
M., & Moore, M
:max_bytes(150000):strip_icc():focal(749x0:751x2)/Mans4-Gallbladder-Gets-Infected-from-GLP-1-042726-95779718fd494bd0a6af2a98bcafc118.jpg)
doi: 10.1111/tpj.12940
According to the American Diabetes Association (ADA), GLP-1 therapy is mainly used for managing type 2 diabetes by aiding in controlling blood sugar levels through stimulating insulin release and decreasing glucose production in the liver while also delaying the digestion process in the stomach
US$ 29.11
US$ 26.44
US$ 25.58
US$ 23.69
